摘要
Phytomedicines have been used for treating or preventing diseases throughout human history.We have been conducting in exploration of traditional or folk herbal medicines as an attempt to identify novel phytocompounds candidates for further development into botanical supplements or drugs for inflammation related diseases,including cancer,acute liver hepatitis,and sepsis.Comparative″OMICS″technology platforms in combination with various in vitro and in vivo cell-and gene-based bioassays,murine skin inflammatory and syngeneic and xenograft mammary tumor and melanoma models are employed to validate the pharmacological effects and the underlying mechanistic insights of the identified bioactive phytocompounds.The therapeutic potential of phytoagents,alone or in combination,in sensitizing the chemotherapeutic drug efficacy and/or reduction of its side effects in tumor-bearing mice are investigated.In addition,how phytoagents modulate pro-or anti-inflammatory lipid mediators,such as oxylipins,and related signaling cascades systemically or at organ levels are also addressed for understanding sepsis or cancer pathogenesis and the modes of action of bioactive phytoagents.
Phytomedicines have been used for treating or preventing diseases throughout human history.We have been conducting in exploration of traditional or folk herbal medicines as an attempt to identify novel phytocompounds candidates for further development into botanical supplements or drugs for inflammation related diseases,including cancer,acute liver hepatitis,and sepsis.Comparative″OMICS″technology platforms in combination with various in vitro and in vivo cell-and gene-based bioassays,murine skin inflammatory and syngeneic and xenograft mammary tumor and melanoma models are employed to validate the pharmacological effects and the underlying mechanistic insights of the identified bioactive phytocompounds.The therapeutic potential of phytoagents,alone or in combination,in sensitizing the chemotherapeutic drug efficacy and/or reduction of its side effects in tumor-bearing mice are investigated.In addition,how phytoagents modulate pro-or anti-inflammatory lipid mediators,such as oxylipins,and related signaling cascades systemically or at organ levels are also addressed for understanding sepsis or cancer pathogenesis and the modes of action of bioactive phytoagents.
出处
《中国药理学与毒理学杂志》
CAS
CSCD
北大核心
2015年第S1期11-11,共1页
Chinese Journal of Pharmacology and Toxicology
